Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Surgical Sciences is delighted to announce that the COPE Consortium has completed its trial recruitment in its European liver study.

The study compares the benefits of warm liver perfusion using the OrganOx metra device with the standard care of static cold storage and was carried out across seven European transplant centres. This is the world’s first multi-centre randomised clinical trial of its kind.

COPE transplanted its 220th liver, achieving their recruitment target, on 9 March 2016 at the Queen Elizabeth Hospital in Birmingham (UK) after being randomised to normothermic machine perfusion. In total, the trial recruited for 19 months with the first liver transplanted at the end of June 2014.

Margaux Laspeyres, COPE Project Manager, commented: ‘We are thrilled to have achieved this important milestone and would like to thank the entire WP2 team with particular thanks to all participating centres and OrganOx for their ongoing support. Congratulations to the entire team and we look forward to our trial's results.’

The team will now ensure a complete set of data follow-up for each trial patient before starting data analysis.

Read more about COPE’s liver trial.

Similar stories

Life-changing results from DRWF Human Islet Isolation Facility at NDS

A new documentary film launched by the Diabetes Research and Wellness Foundation (DRWF) on World Diabetes Day 2022 features an interview with Professor Paul Johnson, as he describes life-changing results from the DRWF Human Islet Isolation Facility at the Nuffield Department of Surgical Sciences (NDS).

Dimitrios Doultsinos wins Young Investigator Award from the Prostate Cancer Foundation

Dr Dimitrios Doultsinos, a John Black Research Fellow in Prostate Oncology at Oxford University's Nuffield Department of Surgical Sciences (NDS), was one of this year’s recipients of the highly coveted Prostate Cancer Foundation (PCF) Young Investigator Award.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

Blog posts

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.